Better is faster....Aerogen Ultra

New clinical outcome data demonstrates how Aerogen Ultra is transforming the treatment 
of patients in the Emergency Department.

Study Design
A retrospective chart review of 1,594 patients at St. John Hospital and Medical Center, Detroit compared clinical outcomes associated with the use of a hospital standard small volume nebuliser (SVN) versus the Aerogen Ultra.

Study Objectives
To determine whether the improved aerosol delivery of bronchodilators would have a positive effect on respiratory patients receiving treatment in the ED in terms of:
•  admission rates
•  discharge rates 

•  total salbutamol dose

Aerogen  Ultra 
How does it work?
Our unique palladium vibrating mesh technology is a breakthrough in aerosol drug delivery and is at the heart of all our products. The central aperture plate is perforated with 1,000 precision formed holes that vibrate at 128,000 times per second to produce the optimum particle size for deep airway penetration.

BETTER 

IS FASTER

• Aerogen Ultra delivers  significantly more medication in half the time
• Aerogen Ultra delivers a 6-fold increase in medication to the patient’s lungs compared with a standard small volume nebuliser (SVN)

Images of healthy lungs after aerosolised drug 

treatment by Aerogen Ultra and SVN.

•  Lung dose delivered: Ultra (34.1%), SVN (5.2%)

•  Residual dose volume: Ultra (2.4%), SVN (62.8%)